# OneBlood - Crestview – FDA Inspection, Apr 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/oneblood-crestview/5fca8b1f-7699-4c80-ac68-2563e60192ee
Source feed: FDA_Inspections

> FDA inspection 1086056 of OneBlood - Crestview, April 09, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 630. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086056
- Company Name: OneBlood - Crestview
- Inspection Date: 2019-04-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1208645 - 2023-05-29
- FDA Inspection 1012287 - 2017-02-03
- FDA Inspection 941335 - 2015-09-03
- FDA Inspection 864463 - 2014-01-31
- FDA Inspection 817575 - 2013-01-31

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/barbara-t-carmichael/4c451805-e327-450d-b2e5-48a40f6232fe)

Company: https://www.keypedia.com/companies/oneblood-crestview/04f563d4-1df2-4a6e-a665-deb45e0e3bbe

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d